APO Research, Inc.

Find your market.

Compare the product scope, applications and research editions relevant to your next decision.

Our research approach
Browse the complete product directory →

9,053 topics, 45,265 reports

Clear all filters

Pharma & Healthcare

PD-1 and PD-L1 Inhibitors

PD-1 inhibitors and PD-L1 inhibitors are a group of checkpoint inhibitors being developed for the treatment of cancer. PD-1 and PD-L1 are both proteins present on the surface of cells. Immune checkpoint inhibitors such as these are emerging as a front-line treatment for several types of cancer.

Types
PD-1 Inhibitors · PD-L1 Inhibitors
Applications
Solid Tumors · Blood-related Tumors

5 editions30 December 2025

View 5 research editions
$4,250Single user · USD · Market Outlook & Growth OpportunitiesExplore product: SchisandraCompare research options for Schisandra

Pharma & Healthcare

Eye Drops & Lubricants

Eye drops are liquid solutions or suspensions intended for administration into the eye, applied directly to the surface of the eye usually in small amounts such as a single drop or a few drops. Eye drops usually contain saline to match the salinity of the eye. Drops containing only saline and sometimes a lubricant are often used as artificial tears to treat dry eyes or simple eye irritation such as itching or redness. Eye drops may also contain one or more medications to…

Types
Antibiotics · Hormone · Artificial Tears
Applications
Eye Disease · Eye Care · Others

5 editions21 December 2025

View 5 research editions

Pharma & Healthcare

Oncaspar

Oncaspar is a cancer medicine used in adults and children to treat acute lymphoblastic leukaemia (ALL), a cancer of white blood cells called lymphoblasts. Oncaspar is used in combination with other cancer medicines.

Types
Lyophilized Oncaspar · Liquid Oncaspar
Applications
Large Hospital · Small & Medium Hospital

5 editions20 December 2025

View 5 research editions
$3,950Single user · USD · Market StructureExplore product: OncasparCompare research options for Oncaspar
APO Research, Inc.